Serum Institute applies for trials of another COVID-19 vaccine
PTI, Jan 30, 2021, 4:28 PM IST
Pune: Serum Institute of India (SII) CEO Adar Poonawalla on Saturday said his company has applied to start the trials of another COVID-19 vaccine and that it hopes to launch it by June 2021.
The city-based firm has already produced Covishield vaccine, co-developed by the University of Oxford and British-Swedish company AstraZeneca. The Centre has purchased 11 million doses of Covishield vaccine for the ongoing inoculation drive.
In a tweet, Poonawalla said, “Our partnership for a COVID-19 vaccine with @Novavax has also published excellent efficacy results. We have also applied to start trials in India. Hope to launch #COVOVAX by June 2021!”
The country launched its COVID-19 vaccination drive from January 16 in what Prime Minister Narendra Modi has called the world’s largest inoculation programme with priority to be given to nearly three crore healthcare and frontline workers.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
IT employee, lover arrested in murder of Kochi woman
ED conducts raids in Delhi-NCR in real estate ‘fraud’ linked money-laundering case
Delhi Police arrests man for stealing gold jewellery worth Rs 1 crore
INDIA bloc seeking JPC probe into Adani ‘scam’, govt scared of debate: Congress after LS, RS adjourned
Youth Congress demands Adani’s arrest over USD 250 mn bribery charge
MUST WATCH
Latest Additions
Sensex reclaims 80k mark; Nifty surges over 1% after BJP-led Mahayuti’s win in Maharashtra
IT employee, lover arrested in murder of Kochi woman
IPL Auction 2025 | GT buy Washington Sundar for Rs 3.20 crore; Shaw, Shardul go unsold
ED conducts raids in Delhi-NCR in real estate ‘fraud’ linked money-laundering case
ED conducts raids in Delhi-NCR in real estate ‘fraud’ linked money-laundering case
Thanks for visiting Udayavani
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.